HalpernJ.PaoloD.HuangA. Informed consent for early phase clinical trials: Therapeutic misestimation and appreciation. Journal of Medical Ethics [in press].
4.
HendersonG. E.ChurchillL. R.DavisA. M.EasterM. M.GradyC.JoffeS.. . . ZimmerC. R. (2007). Clinical trials and medical care: Defining the therapeutic misconception. PLoS Medicine, 4(11), e324. doi:10.1371/journal.pmed.0040324
JeffordM.MooreR. (2008). Improvement of informed consent and the quality of consent documents. The Lancet Oncology, 9, 485-493. doi:10.1016/S1470-2045(08)70128-1
7.
KimS. Y. H.De VriesR.ParnamiS.WilsonR.KimH. M.FrankS.. . .KieburtzK. (2015). Are therapeutic motivation and having one’s own doctor as researcher sources of therapeutic misconception?Journal of Medical Ethics, 41, 391-397.
8.
MerrittM. (2005). Moral conflict in clinical trials. Ethics, 115, 306-330. doi:10.1086/426305
9.
PentzR. D.WhiteM.HarveyR. D.FarmerZ. L.LiuY.LewisC.. . . KhuriF. R. (2012). Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials. Cancer, 118, 4571-4578.